SCHEMBL4020976

SCHEMBL4020976

Fc1ccc(CC2(COCc3cc(C(F)(F)F)cc(C4CC4)n3)CCNCC2)cc1

nearest known ligand 0.64

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 19/20 0.64
SLC6A4 P31645 19/20 0.64
KCNH2 Q12809 19/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4020760 0.85 TACR1 (0.56) TACR1SLC6A4KCNH2
SCHEMBL4023476 0.78 TACR1 (0.45) TACR1SLC6A4KCNH2
SCHEMBL12050388 0.78 TACR1 (1.00) TACR1SLC6A4KCNH2
SCHEMBL3934126 0.74 TACR1 (0.43) TACR1SLC6A4KCNH2
SCHEMBL4020971 0.74 TACR1 (1.00) TACR1SLC6A4KCNH2
SCHEMBL5592060 0.71 TACR1 (0.66) TACR1
SCHEMBL12050386 0.70 TACR1 (1.00) TACR1SLC6A4KCNH2
SCHEMBL4185354 0.69 TACR1 (1.00) TACR1SLC6A4KCNH2
SCHEMBL14304687 0.69 TACR1 (0.78) TACR1SLC6A4KCNH2
SCHEMBL12050188 0.69 TACR1 (0.71) TACR1SLC6A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009096941-A1 SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-08-06 WO disclosed
EP-2069328-A2 4-ARYLALKOXYMETHYL-4-PHENYL PIPERIDINES AND THEIR USE AS NEUROKININ RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CNS DISORDERS Brystol-Myers Squibb Company (US) 2009-06-17 EP disclosed
WO-2008014247-A2 4 -ARYLALKOXYMETHYL-4- PHENYL PIPERIDINES AND THEIR USE AS NEUROKININ RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CNS DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-01-31 WO disclosed